SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-23-118253
Filing Date
2023-11-14
Accepted
2023-11-15 09:08:12
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 tm2329257-3_s3.htm S-3 668947
2 EXHIBIT 1.2 tm2329257d2_ex1-2.htm EX-1.2 228812
3 EXHIBIT 4.6 tm2329257d2_ex4-6.htm EX-4.6 374300
4 EXHIBIT 5.1 tm2329257d2_ex5-1.htm EX-5.1 34290
5 EXHIBIT 5.2 tm2329257d2_ex5-2.htm EX-5.2 7435
6 EXHIBIT 23.2 tm2329257d2_ex23-2.htm EX-23.2 2154
7 EX-FILING FEES tm2329257d2_ex-filingfees.htm EX-FILING FEES 34869
8 GRAPHIC lg_rezolute-4clr.jpg GRAPHIC 8229
  Complete submission text file 0001104659-23-118253.txt   1363425
Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: S-3 | Act: 33 | File No.: 333-275562 | Film No.: 231409198
SIC: 2834 Pharmaceutical Preparations